Transmission origin: Sector Seven, Observation Post Delta Earth date: April–May 2026 Subject count: 3 anomalous behaviors documented

Earth's regulatory authority approved the first gene modification procedure for a condition they call genetic hearing loss. 1

Affected humans possess a non-functional copy of a gene designated OTOF, responsible for producing a protein called otoferlin, which transmits signals from the inner ear to the brain. 2

The correction is delivered via surgical injection directly into the sound-processing chamber. Our translators initially classified this as installing a listening device. We stand by that interpretation. Eighty percent of subjects reported restored auditory function — 42% achieved normal hearing including whispers by week 48. 2

Mechanism: a dual AAV1 vector delivers a functional OTOF gene copy directly into cochlear hair cells. 3

A daily oral tablet. The first-ever PROTAC protein degrader approved by Earth's regulatory authority. 4

Rather than blocking a rogue protein — a mutated estrogen receptor driving tumor growth in ER+/HER2−, ESR1-mutated advanced breast cancer — it recruits the cell's own waste disposal system to eliminate it entirely. Targeted. Permanent. 5

Clinical trials (VERITAC-2, n=270 ESR1m+ patients) showed a 43% reduction in risk of disease progression or death versus the previous standard of care, fulvestrant. 4

Our waste management specialists described this as civilized.

Humans have a condition called hereditary angioedema — a genetic malfunction causing random, life-threatening swelling throughout the body. Their solution: use CRISPR molecular scissors to permanently disable the KLKB1 gene responsible for producing kallikrein, the swelling trigger. 6

Not block it. Not treat it. Delete the instructions for making it. One intravenous dose. Administered once.

Phase 3 HAELO trial (80 patients): 87% reduction in attack frequency versus placebo. 62% of treated subjects remained attack-free and medication-free for 6 months. 6

This is not medical intervention. This is a system update.

Earth organisms are editing their own source code — deactivating proteins, rewiring gene sequences, dismantling inherited malfunctions. Their researchers appear excited. Their regulatory authorities appear cautious. We are monitoring.

This has been Alien Field Report Zero-Zero-One. Next month: we investigate organisms consuming engineered molecules to reshape their own mass. Until then — maintain safe observation distance.